drugset / Trial / NCT04225195

Amphotericin B Cholesteryl Sulfate Complex for Injection(ABCD) in the Treatment of Invasive Candidiasis and Invasive Aspergillosis

NCT04225195 ↗

NaSingle-groupOpen-labelTreatment

Summary

This is an open, multicenter clinical trial of ABCD for invasive candidiasis and invasive aspergillosis.

Timeline

Start
2020-01
Primary completion
2022-04
Completion
2022-06

Drugs

EvaluationDrugModalityDoseRoute
Subject ABCD Unknown 3 mg/kg Intravenous
Subject ABCD Unknown 4 mg/kg Intravenous